Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)
CNY 3.21
(-0.93%)
CNY 3.21
(-0.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.76 Billion | 1.87 Billion | 2.23 Billion | 2.38 Billion | 2.74 Billion | 2.35 Billion |
| Cost of Revenue | 1.52 Billion | 1.45 Billion | 1.71 Billion | 1.83 Billion | 2.03 Billion | 1.51 Billion |
| Gross Profit | 240.58 Million | 415.63 Million | 521.73 Million | 542.69 Million | 711.15 Million | 840.12 Million |
| Operating Expenses | 570.91 Million | 395.94 Million | 462.56 Million | 391.11 Million | 512.5 Million | 473.5 Million |
| Selling, General and Administrative Expenses | 325.37 Million | 157.1 Million | 186.95 Million | 195.32 Million | 318.52 Million | 309.39 Million |
| Research and Development Expenses | 70.55 Million | 48.14 Million | 49.01 Million | 48.06 Million | 55.11 Million | 56.47 Million |
| Other Expenses | 22.9 Million | 3.57 Million | -27.22 Million | -16.05 Million | -8.78 Million | -79.03 Million |
| Cost and Expenses | 1.98 Billion | 1.85 Billion | 2.17 Billion | 2.23 Billion | 2.54 Billion | 1.98 Billion |
| Operating Income | -219.49 Million | 13.77 Million | -818.54 Million | 227.74 Million | 184.16 Million | 348.66 Million |
| Interest Expense | 6.66 Million | 5.5 Million | 9.28 Million | 12.16 Million | 2.98 Million | 1.28 Million |
| Income Tax Expense | 22.92 Million | -19.53 Million | -47.54 Million | 20.41 Million | 20.37 Million | 58.96 Million |
| Earnings before Tax | -198.93 Million | 17.35 Million | -845.77 Million | 211.68 Million | 175.37 Million | 269.63 Million |
| Net Income | -195.32 Million | 45.94 Million | -791.2 Million | 192.3 Million | 161.53 Million | 216.57 Million |
| Earnings Per Share Basic | -0.09 | 0.02 | -0.38 | 0.09 | 0.08 | 0.11 |
| Earnings Per Share Diluted | -0.09 | 0.02 | -0.38 | 0.09 | 0.08 | 0.10 |
| Weighted Average Shares Outstanding | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion |
| Gross Margin | 0.14 | 0.22 | 0.23 | 0.23 | 0.26 | 0.36 |
| EBIT Margin | 0.01 | 0.11 | 0.11 | 0.19 | 0.13 | 0.19 |
| Profit Margin | -0.11 | 0.02 | -0.35 | 0.08 | 0.06 | 0.09 |
| EBITDA | 12.02 Million | 213.54 Million | -625.78 Million | 410.96 Million | 336.83 Million | 421.7 Million |
| Earnings Before Tax Margin | -0.12 | 0.01 | -0.37 | 0.10 | 0.07 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 232.94 Million | 345.55 Million | 271.32 Million | 338.2 Million | 1.76 Billion | 395.2 Million |
| Cost of Revenue | 157.32 Million | 239.23 Million | 193.4 Million | 340.62 Million | 1.52 Billion | 306.07 Million |
| Gross Profit | 75.62 Million | 106.32 Million | 77.92 Million | -2.41 Million | 240.58 Million | 89.13 Million |
| Operating Expenses | 105.6 Million | 97.51 Million | 89.76 Million | 233.36 Million | 460.08 Million | 111.88 Million |
| Selling, General and Administrative Expenses | 151.69 Million | 34.86 Million | 82.23 Million | 119.26 Million | - | 211.16 Million |
| Research and Development Expenses | 12.92 Million | 12.34 Million | 8.85 Million | 15.39 Million | - | 17.83 Million |
| Other Expenses | -59.01 Million | -2.47 Million | 1.32 Million | -98.7 Million | -82.18 Million | 419.58 Thousand |
| Cost and Expenses | 262.92 Million | 336.74 Million | 283.16 Million | 573.99 Million | 1.98 Billion | 417.95 Million |
| Operating Income | -32.03 Million | 10.89 Million | -11.84 Million | -235.78 Million | -219.49 Million | -12.77 Million |
| Interest Expense | 1.99 Million | 2.5 Million | 3.76 Million | 1.13 Million | 6.66 Million | 959.41 Thousand |
| Income Tax Expense | 895.69 Thousand | 1.26 Million | 1.03 Million | 5.57 Million | 22.92 Million | 4.79 Million |
| Earnings before Tax | -32.33 Million | 7.88 Million | 1.07 Million | -235.73 Million | -180.19 Million | -12.35 Million |
| Net Income | -31.76 Million | 3.39 Million | 2.9 Million | -235.39 Million | -195.32 Million | -11.87 Million |
| Earnings Per Share Basic | -0.02 | 0.00 | 0.00 | -0.11 | - | -0.01 |
| Earnings Per Share Diluted | -0.02 | 0.00 | 0.00 | -0.11 | - | -0.01 |
| Weighted Average Shares Outstanding | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion |
| Gross Margin | 0.32 | 0.31 | 0.29 | -0.01 | 0.14 | 0.23 |
| EBIT Margin | -0.13 | 0.03 | 0.01 | -0.54 | - | -0.00 |
| Profit Margin | -0.14 | 0.01 | 0.01 | -0.70 | -0.11 | -0.03 |
| EBITDA | -30.33 Million | 9.89 Million | 2.05 Million | -183.2 Million | - | -1.71 Million |
| Earnings Before Tax Margin | -0.14 | 0.03 | -0.04 | -0.70 | -0.12 | -0.03 |
PLAOW
JELD
004170
QUADRANT
3691
TRUX